Transcriptome-based deep learning analysis identifies drug candidates targeting protein synthesis and autophagy for the treatment of muscle wasting disorder

참고문헌 (79)

1. Larsson, L., "Sarcopenia : aging-related loss of muscle mass and function", Physiol. Rev, 99, pp.427~511 (2019)
2. Cruz-Jentoft, A. J., "Sarcopenia", Lancet, 393, pp.2636~2646 (2019)
3. Grimby, G., "The ageing muscle", Clin. Physiol, 3, pp.209~218 (1983)
4. Brown, J. C., "Sarcopenia and mortality among a population-based sample of community-dwelling older adults", J. Cachexia Sar copenia Muscle, 7, pp.290~298 (2016)
5. Wheelwright, S., "A systematic review of health-related quality of life instruments in patients with cancer cachexia", Support. Care Cancer, 21, pp.2625~2636 (2013)
6. Couch, M. E., "Cancer cachexia update in head and neck cancer : pathophy siology and treatment", Head Neck, 37, pp.1057~1072 (2015)
7. Hopkinson, J. B., "What to eat when off treatment and living with involuntary weight loss and cancer : a systematic search and narrative review", Support. Care Cancer, 19, pp.1~17 (2011)
8. Hopkinson, J. B., "The prevalence of concern about weight loss and change in eating habits in people with advanced cancer", J. Pain Symptom Manag, 32, pp.322~331 (2006)
9. Morishita, S., "Prevalence of sarcopenia in cancer patients : review and future directions", Int. J. Phys. Med. Rehabil, 4, pp.342~ (2016)
10. Lin, T. -Y., "Impact of sarcopenia on the prognosis and treatment of lung cancer : an umbrella review", Discov. Oncol, 13, pp.115~ (2022)
11. Tantai, X., "Effect of sarcopenia on survival in patients with cirrhosis : a meta analysis", J. Hepatol, 76, pp.588~599 (2022)
12. Verdijk, L. B., "Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly", Am. J. Physiol. Endocrinol. Metab, 292, pp.E151~E157 (2007)
13. Marcus, R. L., "Fat modulates the relationship between sarcopenia and physical function in nonobese older adults", Curr. Ger ontol. Geriatr. Res, 2012, pp.216185~ (2012)
14. Morgan, J. E., "Muscle satellite cells", Int. J. Biochem. Cell Biol, 35, pp.1151~1156 (2003)
15. Fu, X., "Stem cell activation in skeletal muscle regeneration", Cell Mol. Life Sci, 72, pp.1663~1677 (2015)
16. Capers, C. R., "Multinucleation of skeletal muscle in vitro", J. Biophys. Biochem. Cytol, 7, pp.559~566 (1960)
17. Chen, M., "Skeletal muscle oxidative stress and inflammation in aging : focus on antioxidant and anti-inflammatory therapy", Front. Cell Dev. Biol, 10, pp.964130~ (2022)
18. Englund, D. A., "Skeletal muscle aging, cellular senescence, and senotherapeutics : current knowledge and future direc tions", Mech. Ageing Dev, 200, pp.111595~ (2021)
19. Minet, A. D., "Cultured senescent myoblasts derived from human vastus lateralis exhibit normal mitochondrial ATP synthesis capacities with cor relating concomitant ROS production while whole cell ATP production is decreased", Biogerontology, 13, pp.277~285 (2012)
20. Palomero, J., "Aging increases the oxidation of dichlorohydrofluorescein in single isolated skeletal muscle fibers at rest, but not during contractions", Am. J. Physiol. Regul. Integr. Comp. Physiol, 305, pp.R351~R358 (2013)
21. Komatsu, M., "Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice", J. Cell Biol, 169, pp.425~434 (2005)
22. Call, J. A., "Ulk1-mediated autophagy plays an essential role in mitochondrial remodeling and functional regeneration of skeletal muscle", Am. J. Physiol. Cell Physiol, 312, pp.C724~C732 (2017)
23. Fortini, P., "The fine tuning of metabolism, autophagy and differentiation during in vitro myogenesis", Cell Death Dis, 7, pp.e2168~ (2016)
24. Remels, A. H., "Regulation of mitochondrial biogenesis during myogenesis", Mol. Cell Endocrinol, 315, pp.113~120 (2010)
25. Sin, J., "Mitophagy is required for mitochondrial biogenesis and myogenic differentiation of C2C12 myoblasts", Autophagy, 12, pp.369~380 (2016)
26. Ebadi, M., "Sarcopenia in cir rhosis : from pathogenesis to interventions", J. Gastroenterol, 54, pp.845~859 (2019)
27. Bartnik, B. L., "Macrophages : their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress", Mult. Scler, 6, pp.37~42 (2000)
28. Sharma, B., "Role of pro-inflammatory cytokines in regulation of ske letal muscle metabolism : a systematic review", Curr. Med. Chem, 27, pp.2161~2188 (2020)
29. Park, S. S., "Molecular mechanisms and therapeutic interventions in sarcopenia", Osteoporosis Sarcopenia, 3, pp.117~122 (2017)
30. Zhang, S., "Regulation of mTORC1 by amino acids in mammalian cells : a general picture of recent advances", Anim. Nutr, 7, pp.1009~1023 (2021)
31. Ferri, E., "Role of age-related mitochondrial dysfunction in sarcopenia", Int. J. Mol. Sci, 21, pp.5236~ (2020)
32. Cesari, M., "Challenges in the development of drugs for sarcopenia and frailty-report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force", J. Frailty Aging, 11, pp.135~142 (2022)
33. Cheng, F., "Systems biology-based investigation of cellular antiviral drug targets identified by gene-trap insertional mutagenesis", PLoS Comput. Biol, 12, pp.e1005074~ (2016)
34. Zeng, X., "Target identification among known drugs by deep learning from heterogeneous networks", Chem. Sci, 11, pp.1775~1797 (2020)
35. Kim, S. K., "Identification of drug combinations on the basis of machine learning to maximize anti-aging effects", PLoS ONE, 16, pp.e0246106~ (2021)
36. Wu, Z., "Network-based drug repositioning", Mol. Biosyst, 9, pp.1268~1281 (2013)
37. Yang, F., "Machine learning applications in drug repurposing", Interdiscip. Sci, 14, pp.15~21 (2022)
38. Siu, P. M., "Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubes", Life Sci, 84, pp.468~481 (2009)
39. Fan, X., "H2O2-induced mitochondrial fragmentation in C2C12 myocytes", Free Radic. Biol. Med, 49, pp.1646~1654 (2010)
40. Portier, G. L., "Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium", InVitroCell. Dev. Biol. Anim, 35, pp.219~227 (1999)
41. Mosmann, T., "Rapid colorimetric assay for cellular growth and survival : application to proliferation and cytotoxicity assays", J. Immunol. Methods, 65, pp.55~63 (1983)
42. Guardiola, O., "Induction of acute skeletal muscle regeneration by cardiotoxin injection", J. Vis. Exp, 119, pp.54515~ (2017)
43. Ogawa, N., "A simple quantitative bradykinesia test in MPTP-treated mice", Res. Commun. Chem. Pathol. Pharmacol, 50, pp.435~441 (1985)
44. Aartsma-Rus, A., "Assessing functional performance in the Mdx mouse model", J. Vis. Exp, 85, pp.e51303~ (2014)
45. Ábrigo, J., "Role of oxidative stress as key regulator of muscle wasting during cachexia", Oxid. Med. Cell Longev, 2018, pp.2063179~ (2018)
46. Mantovani, G., "Cachexia and oxidative stress in cancer : an innovative therapeutic management", Curr. Pharm. Des, 18, pp.4813~4818 (2012)
47. Brown, J. L., "Cancer cachexia in a mouse model of oxidative stress", J. Cachexia Sarcopenia Muscle, 11, pp.1688~1704 (2020)
48. Barreiro, E., "Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats", FEBS Lett, 579, pp.1646~1652 (2005)
49. Wang, L., "Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke", Antioxidants, 11, pp.2377~ (2022)
50. Gutiérrez-Uzquiza, Á., "p38α mediates cell survival in response to oxidative stress via induction of anti oxidant genes: effect on the p70S6K pathway", J. Biol. Chem, 287, pp.2632~2642 (2012)
51. Pansters, N. A. M., "Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle", Biochim. Biophys. Acta Mol. Basis Dis, 1852, pp.490~506 (2015)
52. Velden, J. L. J. V. D., "Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3β", Am. J. Physiol. Cell Physiol, 292, pp.C1636~C1644 (2007)
53. Li, Y.-P., "TNF-α is a mitogen in skeletal muscle", Am. J. Physiol. Cell Physiol, 285, pp.C370~C376 (2003)
54. Neel, B. A., "Skeletal muscle autophagy : a new metabolic regulator", Trends Endocrinol. Metab, 24, pp.635~643 (2013)
55. Mauthe, M., "Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion", Autophagy, 14, pp.1435~1455 (2018)
56. Ye, H., "Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis", BMC Neurol, 16, pp.178~ (2016)
57. Christensen, J. F., "Muscle dysfunction in cancer patients", Ann. Oncol, 25, pp.947~958 (2014)
58. Dennison, E. M., "Epidemiology of sarcopenia and insight into possible therapeutic targets", Nat. Rev. Rheumatol, 13, pp.340~347 (2017)
59. Ligibel, J. A., "Sarcopenia in aging, obesity, and cancer", Transl. Cancer Res, 9, pp.5760~ (2020)
60. Loeffler, J. P., "The role of skeletal muscle in amyotrophic lateral sclerosis", Brain Pathol, 26, pp.227~236 (2016)
61. Zabirowicz, E. S., "Pharmacology and Physiology for Anesthesia", pp.671~692 (2019), Elsevier
62. Snyder, S. H., "Adenosine receptors and behavioral actions of methylxanthines", Proc. Natl Acad. Sci, 78, pp.3260~3264 (1981)
63. Li, Y. P., "Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB acti vation in response to tumour necrosis factor alpha", FASEB J, 12, pp.871~880 (1998)
64. Gomes-Marcondes, M. C., "Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress", Cancer Lett, 180, pp.69~74 (2002)
65. Ji, L. L., "Antioxidant signaling in skeletal muscle : a brief review", Exp. Gerontol, 42, pp.582~593 (2007)
66. Huang, H. -C., "Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription", J. Biol. Chem, 277, pp.42769~42774 (2002)
67. Niture, S. K., "Nrf2 signaling and cell survival", Toxicol. Appl. Pharmacol, 244, pp.37~42 (2010)
68. Wang, D., "Curcumin ameliorates CKD induced mitochondrial dysfunction and oxidative stress through inhibiting GSK 3β activity", J. Nutr. Biochem, 83, pp.108404~ (2020)
69. Bhatnagar, S., "Tumour necrosis factor-α regulates distinct molecular path ways and gene networks in cultured skeletal muscle cells", PLoS ONE, 5, pp.e13262~ (2010)
70. Langen, R. C. J., "Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κΒ", FASEB J, 15, pp.1169~1180 (2001)
71. O’Brien, M. E., "Tumour necrosis factor alpha regulates skeletal myogenesis by inhibiting SP1 interaction with cis-acting regulatory elements within the Fbxl2gene promoter", Mol. Cell. Biol, 40, pp.e00040–00020~ (2020)
72. Langen, R. C., "Tumour necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization", FASEB J, 18, pp.227~237 (2004)
73. Stewart, C., "Multifaceted roles of TNF-α in myoblast destruction : a multitude of signal transduction pathways", J. Cell. Physiol, 198, pp.237~247 (2004)
74. Shen, H. M., "Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death", Mol. Cell Biol, 24, pp.5914~5922 (2004)
75. Li, Y. P., "NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes", Am. J. Physiol. Regul. Integr. Comp. Physiol, 279, pp.R1165~R1170 (2000)
76. Call, J. A., "Autophagy : an essential but limited cellular process for timely skeletal muscle recovery from injury", Autophagy, 16, pp.1344~1347 (2020)
77. Le Bricon, T., "Negative impact of cancer chemotherapy on protein metabolism in healthy and tumour-bearing rats", Metabolism, 44, pp.1340~1348 (1995)
78. Murphy, K. T., "Mechanisms of chemotherapy-induced muscle wasting in mice with cancer cachexia", JCSM Rapid Commun, 5, pp.102~116 (2022)
79. Wang, J., "A pre-clinical study of sub-anesthetic ketamine as remedy in 5-fluorouracil-induced cachexia model", Life, 13, pp.8~ (2023)

관련 논문AI추천